Let's hope finishing touches on new financing and JV are the real reason for silence.
Seems like more positive news is held back and available than negative. For example,
lawsuits---------mainly settled according to GR
SEC-------------small dollars according to GR and financial stmts.
Cohorts results------all fairly to extremely positive.
Cohorts 2A----wild card but all previous science indicates up trend waiting to happen
JV---------------according to GR management is compensated in 2013 to do this
Financing-----GR says he seeking new financing but also says we have enough for trials.
Weighting these out----i believe we should get good news from something more so than poor news. No new developments will leave me wondering what ACTC has been focused on over the past year.
My conclusion is that if verifiable "FACTS" and detailed evidence are not published towards obtainable objectives stated by management and board, then we start over with Matt V as CEO and look for new CFO with true financial relationships with deep money pockets.